JAMIE CALLAHAN: Open Payments
NPI 1912519398 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 32 payments from 11 companies in 2025. Trend: 2023 $777 · 2024 $827 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $280 |
| Amgen Inc. | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: Wegovy, OTEZLA, Rybelsus, Ozempic, TZIELD, Cologuard Collection Kit, Kerendia, PROCLAIM.
Industry payments across TX — which companies pay providers there.
